Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction

Kei Kurokawa, Toshihide Iwashita, Hideki Murakami, Hironori Hayashi, Kumi Kawai, Masahide Takahashi

Research output: Contribution to journalArticlepeer-review

86 Citations (Scopus)


SNT/FRS2 is a lipid anchored docking protein that contains an amino-terminal myristylation signal, followed by a phosphotyrosine-binding (PTB) domain and a carboxy-terminal region with multiple tyrosine residues. Here we show that the SNT/FRS2 PTB domain binds to RET receptor tyrosine kinase activated by glial cell line-derived neurotrophic factor (GDNF) or multiple endocrine neoplasia (MEN) 2 mutations. Analyses by site directed-mutagenesis revealed that it binds to tyrosine 1062 in RET that is also known to be a binding site for the SHC adaptor protein. Whereas SHC bound to RET was associated with GRB2 and GAB1 proteins, SNT/FRS2 was associated with GRB2 only, suggesting that SNT/FRS2 is involved mainly in the activation of the RAS/mitogen activated protein kinase (MAPK) pathway but not the phosphatidylinositol 3-kinase (PI3-K)/AKT pathway. In addition, phosphorylated SNT/FRS2 appeared to directly complex with SHP-2 tyrosine phosphatase. These results suggest that tyrosine 1062 in RET provides a site for the interaction of multiple signaling molecules and that the balance of SHC and SNT/FRS2 binding may affect the nature of the intracellular signaling for cell proliferation, differentiation and survival induced by activated RET.

Original languageEnglish
Pages (from-to)1929-1938
Number of pages10
Issue number16
Publication statusPublished - 12-04-2001

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research


Dive into the research topics of 'Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction'. Together they form a unique fingerprint.

Cite this